BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23865457)

  • 21. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
    Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
    J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
    PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.
    Cremer SE; Moesgaard SG; Rasmussen CE; Zois NE; Falk T; Reimann MJ; Cirera S; Aupperle H; Oyama MA; Olsen LH
    Res Vet Sci; 2015 Jun; 100():197-206. PubMed ID: 25843893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myxomatous mitral valve disease in the miniature poodle: A retrospective study.
    Meurs KM; Adin D; O'Donnell K; Keene BW; Atkins CE; DeFrancesco T; Tou S
    Vet J; 2019 Feb; 244():94-97. PubMed ID: 30825902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
    Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
    Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM; Jeong DM; Kang MH; Kim SG; Han JI; Park HM
    Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.
    Borgarelli M; Abbott J; Braz-Ruivo L; Chiavegato D; Crosara S; Lamb K; Ljungvall I; Poggi M; Santilli RA; Haggstrom J
    J Vet Intern Med; 2015; 29(2):569-74. PubMed ID: 25818210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
    Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
    Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease.
    Tidholm A; Höglund K; Häggström J; Bodegård-Westling A; Ljungvall I
    J Vet Intern Med; 2013; 27(4):884-9. PubMed ID: 23731204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
    Falk T; Ljungvall I; Zois NE; Höglund K; Olsen LH; Pedersen HD; Häggström J
    J Vet Intern Med; 2013; 27(3):500-6. PubMed ID: 23551840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease.
    Hezzell MJ; Falk T; Olsen LH; Boswood A; Elliott J
    J Vet Cardiol; 2014 Dec; 16(4):257-64. PubMed ID: 25292459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
    Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
    Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
    J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
    Ljungvall I; Höglund K; Carnabuci C; Tidholm A; Häggström J
    J Vet Intern Med; 2011; 25(5):1036-43. PubMed ID: 21848946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.
    Baron Toaldo M; Romito G; Guglielmini C; Diana A; Pelle NG; Contiero B; Cipone M
    J Vet Intern Med; 2018 May; 32(3):914-921. PubMed ID: 29572938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
    Bach MBT; Stougaard CL; Thøfner MS; Reimann MJ; Westrup U; Koch J; Fredholm M; Martinussen T; Berendt M; Olsen LH
    J Vet Intern Med; 2024; 38(2):904-912. PubMed ID: 38391152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
    Mead SE; Beijerink NJ; O'Brien M; Wade CM
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.